Activation of peroxisome proliferator-activated receptor gamma inhibits endothelin-1-induced cardiac hypertrophy via the calcineurin/NFAT signaling pathway

被引:54
作者
Bao, Yingxia [1 ]
Li, Ruifang [1 ]
Jiang, Jianmin [1 ]
Cai, Birong [1 ]
Gao, Jie [1 ]
Le, Kang [1 ]
Zhang, Fangyan [1 ]
Chen, Shaorui [1 ]
Liu, Peiqing [1 ]
机构
[1] Sun Yat Sen Univ, Sch Pharmaceut Sci, Lab Pharmacol & Toxicol, Guangzhou 510080, Guangdong, Peoples R China
基金
中国国家自然科学基金;
关键词
peroxisome proliferator-activated receptor gamma; calcineurin; nuclear factor of activated T-cell; endothelin-1; cardiac hypertrophy;
D O I
10.1007/s11010-008-9848-8
中图分类号
Q2 [细胞生物学];
学科分类号
071009 [细胞生物学]; 090102 [作物遗传育种];
摘要
Peroxisome proliferator-activated receptor gamma (PPAR-gamma) has been described as a negative regulator of cardiac hypertrophy. A better understanding of PPAR-gamma and cardiac hypertrophy may facilitate the development of novel therapeutic strategies to treat heart diseases related to cardiac hypertrophy by mimicking the naturally preferred mechanisms. In the present study, we investigated the interaction between PPAR-gamma and calcineurin/nuclear factor of activated T-cells (NFAT) in endothelin-1 (ET-1)-induced hypertrophy of neonatal rat cardiac myocytes. The results suggest that the treatment of cultured cardiac myocytes with a PPAR-gamma ligand, rosiglitazone, inhibited the ET-1-induced increase in protein synthesis, surface area, calcineurin enzymatic activity, and protein expression. Both the application of rosiglitazone and overexpression of the PPAR-gamma inhibited the nuclear translocation of NFATc4. Moreover, co-immunoprecipitation studies showed that rosiglitazone enhanced the association between PPAR-gamma and calcineurin/NFAT. These results suggest that ET-1-induced cardiac hypertrophy is inhibited by activation of PPAR-gamma, which is at least partly due to cross-talk between PPAR-gamma and calcineurin/NFAT.
引用
收藏
页码:189 / 196
页数:8
相关论文
共 39 条
[1]
ARCO PG, 2000, J BIOL CHEM, V275, P13872, DOI DOI 10.1074/JBC.275.18.13872
[2]
Peroxisome proliferator-activated receptor γ plays a critical role in inhibition of cardiac hypertrophy in vitro and in vivo [J].
Asakawa, M ;
Takano, H ;
Nagai, T ;
Uozumi, H ;
Hasegawa, H ;
Kubota, N ;
Saito, T ;
Masuda, Y ;
Kadowaki, T ;
Komuro, I .
CIRCULATION, 2002, 105 (10) :1240-1246
[4]
Endothelial cell apoptosis induced by the peroxisome proliferator-activated receptor (PPAR) ligand 15-deoxy-Δ12,14-prostaglandin J2 [J].
Bishop-Bailey, D ;
Hla, T .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (24) :17042-17048
[5]
Neuropeptide Y induces cardiomyocyte hypertrophy via calcineurin signaling in rats [J].
Chen, MS ;
Li, XY ;
Dong, Q ;
Li, YH ;
Liang, WB .
REGULATORY PEPTIDES, 2005, 125 (1-3) :9-15
[6]
Inhibition of interleukin-4 production in CD4+ T cells by peroxisome proliferator-activated receptor-γ (PPAR-γ) ligands:: Involvement of physical association between PPAR-γ and the nuclear factor of activated T cells transcription factor [J].
Chung, SW ;
Kang, BY ;
Kim, TS .
MOLECULAR PHARMACOLOGY, 2003, 64 (05) :1169-1179
[7]
Structure, endothelial function, cell growth, and inflammation in blood vessels of angiotensin II-infused rats -: Role of peroxisome proliferator-activated receptor-γ [J].
Diep, QN ;
El Mabrouk, M ;
Cohn, JS ;
Endemann, D ;
Amiri, F ;
Virdis, A ;
Neves, MF ;
Schiffrin, EL .
CIRCULATION, 2002, 105 (19) :2296-2302
[8]
Long-term effects of the PPARγ activator pioglitazone on cardiac inflammation in stroke-prone spontaneously hypertensive rats [J].
Diep, QN ;
Amiri, F ;
Benkirane, K ;
Paradis, P ;
Schiffrin, EL .
CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY, 2004, 82 (11) :976-985
[9]
Calcineurin is activated in rat hearts with physiological left ventricular hypertrophy induced by voluntary exercise training [J].
Eto, Y ;
Yonekura, K ;
Sonoda, M ;
Arai, N ;
Sata, M ;
Sugiura, S ;
Takenaka, K ;
Gualberto, A ;
Hixon, ML ;
Wagner, MW ;
Aoyagi, T .
CIRCULATION, 2000, 101 (18) :2134-2137
[10]
Interference of antihypertrophic molecules and signaling pathways with the Ca2+-calcineurin-NFAT cascade in cardiac myocytes [J].
Fiedler, B ;
Wollert, KC .
CARDIOVASCULAR RESEARCH, 2004, 63 (03) :450-457